 | Up a level |
Arman, A. and Tajik, M. and Nazemipour, M. and Ahmadinejad, Z. and Shahrestanaki, S.K. and Hazrati, E. and Mansournia, N. and Mansournia, M.A. (2021) Risk factors of developing critical conditions in Iranian patients with COVID-19. Global Epidemiology, 3.
Sekhavati, E. and Jafari, F. and SeyedAlinaghi, S. and Jamalimoghadamsiahkali, S. and Sadr, S. and Tabarestani, M. and Pirhayati, M. and Zendehdel, A. and Manafi, N. and Hajiabdolbaghi, M. and Ahmadinejad, Z. and Kouchak, H.E. and Jafari, S. and Khalili, H. and Salehi, M. and Seifi, A. and Golestan, F.S. and Ghiasvand, F. (2020) Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. International Journal of Antimicrobial Agents, 56 (4).
Ahmadinejad, Z. and Abdollahi, A. and Ziaee, V. and Domiraei, Z. and Najafizadeh, S.-R. and Jafari, S. and Ahmadinejad, M. (2016) Prevalence of positive autoimmune biomarkers in the brucellosis patients. Clinical Rheumatology, 35 (10). pp. 2573-2578.
